ArticleBioMed research international2026
Potent Anticancer, Antimicrobial, and Anti-Inflammatory Activities of Boswellia sacra Extracted Oil Nanoemulgel.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Potent Anticancer, Antimicrobial, and Anti-Inflammatory Activities of Boswellia sacra Extracted Oil Nanoemulgel.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBoswellia sacra (B. sacra), the chemical name for frankincense essential oil, is utilized extensively to treat multiple kinds of cancers as well as skin disorders like acne, infections, and inflammations. The goal of this project is to develop a nanoemulgel using B. sacra oil to enhance its antibacterial, anti-inflammatory, and anticancer effects. B. sacra oil was extracted from oleoresin gum.
methodsThe extracted oil was obtained via the steam distillation process. Then, nanoemulsion formulations were prepared using the self-nanoemulsifying technique with Tween 80 and Span 80, incorporating the selected nanoemulsion formula. The resulting nanoemulsion was then incorporated with Carbopol hydrogel to produce nanoemulgel.
resultsThe nanoemulsion showed a droplet size of 120.03 nm and a PDI below 0.3. The zeta potential for nanoemulgel was -35 mV at 0.4% Carbopol concentration, and the nanoemulgel formulation demonstrated pseudo-plastic behavior with no significant change in droplet size or PDI. The nanoemulgel has an antibacterial effect against various types of bacteria. The anticancer effect of B. sacra oil nanoemulgel was tested on different types of cancerous cells, which were: LX2, Hep-G2, Hela, MCF-7, and 3 T3, and the IC50 values were 186.2, 79.43, 186.2, 128.82, and 107.15 μg/mL, respectively. The IC
conclusionThe B. sacra oil nanoemulgel developed in this study has superior biological activities to those found in pure oil. Nanoemulgel is a promising delivery technique for improving several properties of pharmaceutical dosage forms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.